Active Ingredient Sotatercept
Active Ingredient Details
What is Sotatercept?
a dimeric fusion protein consisting of the extracellular domain of the human ActRIIA linked to the Fc portion of human IgG1. On March 26, 2024, FDA-approved sotatercept for the treatment of pulmonary arterial hypertension (PAH).
How many products in the NDC database contain Sotatercept?
The NDC database has 3 products with the active ingredient Sotatercept. The following table lists all the products that have this active ingredient.
NDC Products with Sotatercept
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0074-2242 | Proprietary Name: | Sotatercept | Liquid | Abbvie Inc. | ACTIVE | ||
| 68225-243 | Proprietary Name: | Sotatercept-csrk | Injection, Powder, Lyophilized, For Solution | Patheon Italia S.p.a. | ACTIVE | ||
| 68225-244 | Proprietary Name: | Sotatercept-csrk | Injection, Powder, Lyophilized, For Solution | Patheon Italia S.p.a. | ACTIVE |
